Prof. ABDURRAHMAN TUFAN

Publication Network

Articles 63

1. Familial aggregation in Behcet's Disease: Sibling history as a risk factor for Neuro-Behcet

ATA E. E., ÇAKIR İ. Y., Eken A., Ergul C., Karacali E., Dalkilic Y. E., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , 2026 (SCI-Expanded, Scopus)

2. Validity and reliability of the Turkish version of the hand scleroDerma lived experience scale

Pala G. G., TORE N. G., Sari F., BAYRAM S., Vasi İ., TUFAN A., et al.

Journal of Bodywork and Movement Therapies , vol.47, pp.60-64, 2026 (ESCI, Scopus)

3. Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry

Sota J., Hinojosa-Azaola A., Martin-Nares E., Sfriso P., Bindoli S., Hissaria P., et al.

FRONTIERS IN IMMUNOLOGY , vol.17, 2026 (SCI-Expanded, Scopus)

4. Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry

Vitale A., Caggiano V., Sbalchiero J., Gavioli F., Lopalco G., Ragab G., et al.

FRONTIERS IN IMMUNOLOGY , vol.17, 2026 (SCI-Expanded, Scopus)

5. The use of non-TNF targeted biologics in Behçet's disease: real-life data from the International AIDA Network Behçet's Disease Registry

Sevik G., Lopalco G., Iannone F., Frassi M., Piga M., Emmi G., et al.

RHEUMATOLOGY , vol.65, no.5, 2026 (SCI-Expanded, Scopus)

6. Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry

Ruscitti P., Masedu F., Vitale A., Caggiano V., Di Cola I., Atzeni F., et al.

FRONTIERS IN IMMUNOLOGY , vol.17, 2026 (SCI-Expanded, Scopus)

7. Assessment of Interleukin-33 Levels in Patients with Familial Mediterranean Fever

DEMİREZEN A., Guler A. A., Karadeniz H., KAVUTÇU M., TUFAN A.

ROMANIAN JOURNAL OF INTERNAL MEDICINE , vol.64, no.1, pp.37-44, 2026 (ESCI, Scopus)

8. Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry

Vitale A., Gavioli F., Caggiano V., Sbalchiero J., Lopalco G., Ragab G., et al.

RHEUMATOLOGY , vol.65, no.2, 2026 (SCI-Expanded, Scopus)

9. Prevalence of gout in the Sincan district of Ankara, Türkiye: a primary care-based cross-sectional study

Kardaş R. C., Ünsal Y., Yıldırım D., TÜZÜN H., İLHAN M. N., KÜÇÜK H., et al.

Turkish Journal of Medical Sciences , vol.56, no.1, pp.23-31, 2026 (SCI-Expanded, Scopus, TRDizin)

10. The Risk of Developing Ocular Involvement Among Behcet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behcet's Disease Registry

Vitale A., Caggiano V., Sbalchiero J., Lopalco G., Ragab G., Guerriero S., et al.

OPHTHALMOLOGY AND THERAPY , vol.15, no.1, pp.223-237, 2026 (SCI-Expanded, Scopus)

11. Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries

Caggiano V., Sbalchiero J., Frassi M., Martin-Nares E., Hinojosa-Azaola A., Sikora M., et al.

FRONTIERS IN MEDICINE , vol.12, 2026 (SCI-Expanded, Scopus)

12. Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network

Caggiano V., Sbalchiero J., Frassi M., Crisafulli F., Cavazzana I., Hinojosa-Azaola A., et al.

Frontiers in Immunology , vol.17, 2026 (SCI-Expanded, Scopus)

13. The clinical assessment of lung involvement in patients with Still's disease, results from the multicentre international AIDA Network Still's Disease Registry

Ruscitti P., Vitale A., Di Cola I., Caggiano V., Palumbo P., Di Cesare E., et al.

RHEUMATOLOGY , vol.64, no.SI, 2025 (SCI-Expanded, Scopus) Sustainable Development

14. Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry.

Gaggiano C., De-la-Torre A., Cardona-López J., Guerriero S., Ragab G., Paroli M. P., et al.

Ophthalmology and therapy , vol.14, no.11, pp.2877-2894, 2025 (SCI-Expanded, Scopus)

15. The utility of machine learning-based decision support system in referral of suspected rheumatic disease.

Babaoğlu H., Satiş H., Kavak Y., Tufan A.

Clinical and experimental rheumatology , 2025 (SCI-Expanded, Scopus)

16. IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.

Calabrese L., Cartocci A., Vitale A., Martín-Nares E., D'Onghia M., Caggiano V., et al.

Clinical and experimental rheumatology , vol.43, no.10, pp.1753-1762, 2025 (SCI-Expanded, Scopus)

17. Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders

Sota J., Breda L., Paroli M. P., Hashad S., de-la-Torre A., Guerriero S., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , vol.109, no.10, pp.1151-1154, 2025 (SCI-Expanded, Scopus) Sustainable Development

18. Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry.

Di Meglio N., Sica C., Vitale A., Caggiano V., Perrella A., Di Martino V., et al.

Frontiers in medicine , vol.12, pp.1662890, 2025 (SCI-Expanded, Scopus)

19. Development and implementation of the International AIDA Network Castleman's disease registry.

Vitale A., Sbalchiero J., Caggiano V., Lazzi S., Tharwat S., Fotis L., et al.

Frontiers in medicine , vol.12, pp.1579182, 2025 (SCI-Expanded, Scopus)

20. Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

Vitale A., Caggiano V., Sbalchiero J., TUFAN A., BATU AKAL E. D., Ragab G., et al.

RHEUMATOLOGY , vol.64, no.8, pp.4776-4787, 2025 (SCI-Expanded, Scopus) Sustainable Development

21. Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.

Sota J., Mejía-Salgado G., Guerriero S., Ragab G., Costi S., Paroli M. P., et al.

Frontiers in medicine , vol.12, pp.1609613, 2025 (SCI-Expanded, Scopus)

22. Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network

Vitale A., Leone F., Caggiano V., Hinojosa-Azaola A., Martin-Nares E., Guaracha-Basanez G. A., et al.

FRONTIERS IN PHARMACOLOGY , vol.16, 2025 (SCI-Expanded, Scopus) Sustainable Development

23. Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Vitale A., Caggiano V., Leone F., Hinojosa-Azaola A., Martín-Nares E., Guaracha-Basañez G. A., et al.

Frontiers in pharmacology , vol.16, pp.1462254, 2025 (SCI-Expanded, Scopus)

24. Development and implementation of the international AIDA network spondylarthritis registry.

Caggiano V., Vitale A., Hinojosa-Azaola A., Guaracha-Basañez G. A., Ruscitti P., Cipriani P., et al.

Frontiers in medicine , vol.12, pp.1509357, 2025 (SCI-Expanded, Scopus)

25. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.

Fisher B. A., Mariette X., Papas A., Grader-Beck T., Bootsma H., Ng W., et al.

Lancet (London, England) , vol.404, no.10452, pp.540-553, 2024 (SCI-Expanded, Scopus)

26. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.

Karadag O., Bolek E. Ç., Ayan G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.

Arthritis & rheumatology (Hoboken, N.J.) , vol.76, no.7, pp.1120-1129, 2024 (SCI-Expanded, Scopus)

27. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.

Vitale A., Caggiano V., Martin-Nares E., Frassi M., Dagna L., Hissaria P., et al.

Seminars in arthritis and rheumatism , vol.66, pp.152430, 2024 (SCI-Expanded, Scopus)

28. The effect of respiratory muscle training on respiratory muscle strength, diaphragm thickness/mobility, and exercise capacity in patients with systemic lupus erythematosus and associated shrinking lung syndrome.

Sari F., OSKAY D., Tufan A.

Lupus , vol.33, no.3, pp.289-292, 2024 (SCI-Expanded, Scopus)

29. Effects of a telerehabilitation-based exercise program in patients with systemic sclerosis.

Sari F., OSKAY D., Tufan A.

Zeitschrift fur Rheumatologie , vol.83, no.Suppl 1, pp.167-174, 2024 (SCI-Expanded, Scopus)

30. Translation and Psychometric Evaluation of the Profile of Fatigue and Discomfort-Sicca Symptoms Inventory (Short Form) for Patients with Primary Sjogren's Syndrome: Validity and Reliability Analysis of the Turkish Version

Sari F., BAYRAM S., Pala G. G., OSKAY D., Tufan A.

EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.11, no.1, 2024 (ESCI, TRDizin)

31. Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.

Ruscitti P., Masedu F., Vitale A., Di Cola I., Caggiano V., Di Muzio C., et al.

RMD open , vol.9, no.4, 2023 (SCI-Expanded, Scopus)

32. Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.

Triggianese P., Vitale A., Lopalco G., Mayrink Giardini H. A., Ciccia F., Al-Maghlouth I., et al.

Internal and emergency medicine , vol.18, no.8, pp.2231-2243, 2023 (SCI-Expanded, Scopus)

33. Effects of interleukin-1 antagonists on de novo and pre-existing damage in patients with familial Mediterranean fever.

Yildirim D., Ozkiziltas B., Vasi I., Karadeniz H., Avanoglu Guler A., Kardas R. C., et al.

Clinical and experimental rheumatology , vol.41, no.10, pp.2056-2061, 2023 (SCI-Expanded, Scopus)

34. The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.

Ruscitti P., Sota J., Vitale A., Lopalco G., Iannone F., Morrone M., et al.

Seminars in arthritis and rheumatism , vol.62, pp.152244, 2023 (SCI-Expanded, Scopus)

35. The assessment of hyposalivation and its impact on mouth disability in systemic sclerosis patients

Guler A. A., KARADENİZ H., Salman R. B., Satış H., Babaoglu H., Atas N., et al.

Ulusal Romatoloji Dergisi , vol.15, no.2, pp.82-88, 2023 (Scopus, TRDizin)

36. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.

Brito-Zerón P., Flores-Chávez A., Horváth I. F., Rasmussen A., Li X., Olsson P., et al.

EClinicalMedicine , vol.61, pp.102062, 2023 (SCI-Expanded, Scopus)

37. COVID-19 Course in Connective Tissue Disease-Related Interstitial Lung Disease Patients

Satış H., ünsal y., TUFAN A.

Van Tıp Dergisi , vol.29, no.3, pp.332-336, 2022 (TRDizin)

38. Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation.

Tufan A., Matucci-Cerinic M.

Turkish journal of medical sciences , vol.51, no.SI-1, pp.3391-3404, 2021 (SCI-Expanded, Scopus, TRDizin)

39. Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database

Bilgin E., Aydin S. Z., Tinazzi I., Bayindir O., Kimyon G., Ozisler C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.3, pp.532-536, 2021 (SCI-Expanded, Scopus)

40. Yaşlı ankilozan spondilitli hastalarda kırık riski ve ilişkili faktörler

Atas N., Candemir B., TORGUTALP M., Babaoglu H., Satış H., Salman R. B., et al.

Ulusal Romatoloji Dergisi , vol.13, no.2, pp.59-65, 2021 (Scopus, TRDizin)

41. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients

Atas N., Eroglu G. A., Sodan H. N., Ozturk B. O., Babaoglu H., Satis H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021 (SCI-Expanded, Scopus)

42. S100 PROTEINS AS AN IMPORTANT REGULATOR OF INFLAMMATION

Salman E., Salman R. B., TUFAN A.

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.53, no.Ek sayı, pp.41-45, 2020 (TRDizin)

43. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review.

Tufan A., Lachmann H. J.

Turkish journal of medical sciences , vol.50, no.SI-2, pp.1591-1610, 2020 (SCI-Expanded, Scopus, TRDizin)

44. Factors associated with damage in patients with familial Mediterranean fever.

Babaoglu H., Armagan B., Bodakci E., Satis H., Atas N., Sari A., et al.

Clinical and experimental rheumatology , no.5, pp.42-48, 2020 (SCI-Expanded, Scopus)

45. Telescoping Fingers in Rheumatoid Arthritis.

Satis H., Tufan A.

The New England journal of medicine , vol.381, no.24, 2019 (SCI-Expanded, Scopus)

46. Treatment of anti-TNF-related paradoxic palmoplantar psoriasis in Behcet's disease with azathioprine

Karadeniz H., Atas N., Guler A. A., Tufan A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.6, pp.168, 2019 (SCI-Expanded, Scopus)

47. Turkish lupusPRO: cross-cultural validation study for lupus.

Kaya A., Goker B., Cura E. S., Tezcan M. E., Tufan A., Mercan R., et al.

Clinical rheumatology , vol.33, no.8, pp.1079-84, 2014 (SCI-Expanded, Scopus)

48. MEFV mutation frequency and effect on disease severity in ankylosing spondylitis.

Maraş Y., Akdoğan A., Kisacik B., Kiliç L., Yilmaz E., Tufan A., et al.

Turkish journal of medical sciences , vol.44, no.2, pp.203-7, 2014 (SCI-Expanded, Scopus, TRDizin)

49. Transverse myelitis in Behçet's disease: a series of four cases and review of the literature.

Bitik B., Ucar M., Tezcan M. E., Mercan R., Tufan A., Kocer B., et al.

Clinical and experimental rheumatology , vol.31, no.3 Suppl 77, pp.20-4, 2013 (SCI-Expanded, Scopus)

50. An Unusual Case of Madelung's Disease with Multiple Atypical Fractures.

Tufan A., Mercan R., Kaya A., Tezcan M. E., Bitik B., Ozturk M. A., et al.

Case reports in orthopedics , vol.2012, pp.180506, 2012 (Peer-Reviewed Journal)

51. Familial influence on tibiofemoral alignment.

Tufan A., Meulenbelt I., Bijsterbosch J., Kroon H. M., Bierma-Zeinstra S. M. A., Nelissen R. G., et al.

Annals of the rheumatic diseases , vol.69, no.3, pp.542-5, 2010 (SCI-Expanded, Scopus)

52. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.

Kalyoncu U., Dizdar O., Erkan Duman A., Karadag O., Tufan A., Yucel O., et al.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis , vol.15, no.1, pp.103-8, 2009 (SCI-Expanded, Scopus)

53. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis.

Kisacik B., Tufan A., Kalyoncu U., Karadag O., Akdogan A., Ozturk M. A., et al.

Joint bone spine , vol.75, no.3, pp.291-4, 2008 (SCI-Expanded, Scopus)

54. Spinal epidural extramedullary hematopoiesis during the complicated course of polycythemia vera.

Tufan A., Koca E., Önal İ., Haznedaroğlu İ. C., Üner A., Özcebe O. I.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.24, no.4, pp.177-80, 2007 (Scopus, TRDizin)

55. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.

Tufan A., Babaoglu M. O., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.

The Journal of rheumatology , vol.34, no.7, pp.1540-4, 2007 (SCI-Expanded, Scopus)

56. Rubinstein-Taybi syndrome and familial Mediterranean fever in a single patient: two distinct genetic diseases located on chromosome 16p13.3.

Kalyoncu U., Tufan A., Karadag O., Kisacik B., Akdogan A., Calguneri M.

Journal of the National Medical Association , vol.98, no.10, pp.1692-3, 2006 (SCI-Expanded, Scopus)

57. Rhabdomyolysis in a patient treated with colchicine and atorvastatin.

Tufan A., Dede D. S., Cavus S., Altintas N. D., Iskit A. B., Topeli A.

The Annals of pharmacotherapy , vol.40, no.7-8, pp.1466-9, 2006 (SCI-Expanded, Scopus)

58. Cauda equina syndrome as a rare manifestation of leukemia relapse during postallograft period.

Onal I. K., Shorbagi A., Göker H., Büyükasýk Y., Ozçakar L., Tufan A., et al.

Journal of the National Medical Association , vol.98, no.5, pp.808-10, 2006 (SCI-Expanded, Scopus)

59. Concurrent presentations of the sarcoidosis, tuberculosis and lymphoma in a single patient.

Tufan A., Ranci O., Sungur A., Topeli A., Haznedaroglu I., Cöplü L.

Respiratory medicine , vol.100, no.5, pp.951-3, 2006 (SCI-Expanded, Scopus)

60. Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome.

Tufan A., Unal N., Koca E., Onal I., Aksu S., Haznedaroglu I.

Annals of hematology , vol.85, no.3, pp.183-4, 2006 (SCI-Expanded, Scopus)

61. Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders.

Kocak Z., Hatipoglu C. A., Ertem G., Kinikli S., Tufan A., Irmak H., et al.

The Journal of infection , vol.52, no.2, 2006 (SCI-Expanded, Scopus)

62. Nonconvulsive status epilepticus due to ifosfamide.

Kilickap S., Cakar M., Onal I. K., Tufan A., Akoglu H., Aksoy S., et al.

The Annals of pharmacotherapy , vol.40, no.2, pp.332-5, 2006 (SCI-Expanded, Scopus)

63. Bone marrow embolism after bone marrow aspiration and biopsy.

Onal I. K., Sümer H., Tufan A., Shorbagi A.

American journal of hematology , vol.78, no.2, pp.158, 2005 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 189

1. POS1090 Clinical Predictors of Treatment Discontinuation in Adult-Onset Stills Disease

ÇAKIR İ. Y., MAHMUTOĞLU Y., KARDAŞ R. C., USLU E., SEZER S., YAYLA M. E., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, Spain, 11 - 14 June 2025, vol.84, pp.1181, (Summary Text)

2. IMPORTANCE OF POTENTIAL PROTHROMBOTIC STATE MARKERS IN BEHÇET'S DISEASE AND CORRELATION WITH VASCULAR ULTRASOUND

Karadeniz H., Mammadov T., Cerit M., Avanoğlu Güler A., Yıldırım D., Vasi İ., et al.

13.ISSAID Meeting, Paris, France, 8 - 10 April 2025, pp.48, (Summary Text) Sustainable Development

3. HEALING OF EROSIONS IN HAND OSTEOARTHRITIS WITH LONG TERM USE OF ANAKINRA

Karadeniz H., Avanoğlu Güler A., Varan Ö., Tufan A., Göker B.

OARSI 2025 World Congress on Osteoarthritis, Incheon, South Korea, 24 April 2025, (Summary Text)

4. AB1017 SLE PATIENTS EXHIBIT WALL THICKENING IN MAJOR VEINS ACROSS THE BODY

KARADENİZ H., YILDIRIM D., İbrahimhanlı N., koç kanık h. n., VASİ İ., DURAN R., et al.

EULAR 2024 |, Viyana, Austria, 12 June 2024, pp.1826-1827, (Full Text)

5. AB1016 SERUM CXCL-13 LEVELS ARE ASSOCIATED WITH ACTIVE NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

TUFAN A., YILDIRIM D., koç kanık h. n., DURAN R., KARDAŞ R. C., KAYA B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.1826, (Summary Text)

6. AB1421 DETERMINATION OF THE RELATIONSHIP BETWEEN SERUM PROTEIN 14-3-3 ETA LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

avcu a., YILDIRIM D., ERDEN A., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A.

European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.2066, (Summary Text)

7. Moyamoya sendromu ve antifosfolipid antikor sendromu birlikteliği

VASİ İ., KARDAŞ R. C., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.

23. ULUSAL ROMATOLOJİ KONGRESİ 2023, Antalya, Turkey, 11 - 15 October 2023, vol.15, pp.201, (Full Text)

8. Ailevi Akdeniz Ateşi hastalarında serum protein 14-3- 3 eta düzeyi ile hastalığın klinik özellikleri arasındaki ilişkinin belirlenmes

Avcu A., YILDIRIM D., ERDEN A., KÜÇÜK H., GÖKER B., ÖZTÜRK M. A., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

9. Moyamoya sendromu ve antifosfolipid antikor sendromu birlikteliğ

VASİ İ., KARDAŞ R. C., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

10. COMPARISON OF SERUM CXCL13 LEVELS BETWEEN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

YILDIRIM D., VASİ İ., BAYKUL M., Gülengül M., Erdek Y., KÜÇÜK H., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

11. L MARKER IN SYSTEMIC SCLEROSISASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

Alp G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

12. CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY

Vitale A., Caggiano V., Maggio M. C., Lopalco G., Emmi G., Sota J., et al.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.1404-1405, (Summary Text)

13. DIFFUSE GENERALIZED VENULITIS AS THE PRIMARY PATHOLOGY OF BEHCET'S DISEASE: A COMPREHENSIVE MAGNETIC RESONANCE VENOGRAPHY STUDY

Karadeniz H., Ucar M., Mammadov T., Guler A. A., Yildirim D., KÜÇÜK H., et al.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.760, (Summary Text)

14. CONVERGENT VALIDITY OF SIX MINUTE STEPPER TEST TO EVALUATE FUNCTIONAL EXERCISE CAPACITY IN PATIENTS WITH SYSTEMIC SCLEROSIS

Bayram S., Tore N. G., Pala G. G., Vasi I., TUFAN A., OSKAY D.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.813-814, (Summary Text)

15. Systemic lupus erythematosus, Physical therapy/Physiotherapy, Quality of life

Sari F., Bayram S., OSKAY D., TUFAN A.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.2132-2133, (Summary Text)

16. VENOUS INFLAMMATION MIGHT BE ONE OF THE FEATURES OF VEXAS SYNDROME AND ASSOCIATED THROMBOSIS

Karadeniz H., CERİT M. N., TUFAN A., Kanthi Y.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.1165, (Summary Text)

17. THE EFFECT OF VITAMIN D DEFICIENCY ON EXERCISE CAPACITY, RESPIRATORY MUSCLE STRENGTH, AND PERIPHERAL MUSCLE STRENGTH IN PATIENTS WITH CONNECTIVE TISSUE DISEASES

Sari F., Sarac D., Bayram S., Yentur S. B., Tore N. G., OSKAY D., et al.

European Congress of Rheumatology (EULAR), Milan, Italy, 31 May - 03 June 2023, pp.1168, (Summary Text)

18. AB0701 PERFORMANCE OF DRAFT 2022 ACR/EULAR CLASSIFICATION CRITERIA IN A TURKISH COHORT OF APL ANTIBODY POSITIVE PATIENTS

KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., KARADENİZ H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1554, (Summary Text)

19. AB0845 A NOVEL MARKER IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

ALP G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1635-1636, (Summary Text)

20. AB1461 COLCHICINE INTOLERANT FAMILIAL MEDITERRANEAN FEVER PATIENTS RECEIVING IL-1 ANTAGONISTS: DO THEY MISS ADVANTAGE OF COMBINATION

YILDIRIM D., Özkızıltaş B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1958-1959, (Summary Text)

21. AB0922 CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME OF SYSTEMIC SCLEROSIS OVERLAP SYNDROME (SSC-OS) IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., DURAN R., Özkızıltaş B., YILDIRIM D., ALP G. T., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1678, (Summary Text)

22. ROMATOİD ARTRİTTE PLANTAR MASAJ UYGULAMASININ VE DOKULU TABANLIK KULLANIMININ DİNAMİK DENGE VE AYAK FONKSİYONLARI ÜZERİNE ETKİSİ: ÖN ÇALIŞMA

Pala G. G., Bayram S., Tufan A., Oskay D.

6. Uluslararası Sağlık Bilimleri ve Yaşam Kongresi, Burdur, Turkey, 2 - 05 March 2023, (Summary Text)

23. Sistemik lupus eritematozuslu hastalarda gebelik sonuçları ve takrolimus deneyimi

VASİ İ., YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., DURAN R., Alp G. T., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

24. Merkezimizde takipli erişkin başlangıçlı Still hastalığı olanların tedavi yanıtları

YILDIRIM D., VASİ İ., ÖZKIZILTAŞ B., KARDAŞ R. C., AVANOĞLU GÜLER A., KARADENİZ H., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

25. İnterlökin 1 blokeri kullananlarda hasar indeksi artisinin izlemi: Tek merkez deneyimi

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

26. The Interobserver and Intraobserver Agreements on HEAD-US in the assessment of Hemophilic Arthropathy

YILMAZ ORULLUOĞLU E., KAYA Z., SATIŞ H., AKDULUM İ., YAZOL M., TUFAN A., et al.

XXX Congress of the International Society on Thrombosis and Haemostasis, Londrina, Brazil, 09 July 2022, pp.669-670, (Full Text)

27. DETERMINING THE RELATIONSHIP BETWEEN SERUM INTERLEUKIN 33 LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., KAVUTÇU M., et al.

EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

28. ATTACKS OF MYALGIA IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: OTHER THAN CALF PAIN

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.

EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Full Text)

29. SERUM INTERLEUKIN 37 LEVELS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS AND ASSOCIATION WITH CLINICAL FEATURES

Fincan A., KAVUTÇU M., ATAŞ N., BABAOĞLU H., Salman R. B., SATIŞ H., et al.

EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

30. DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLECENTER STUDY

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.

EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Full Text)

31. EVALUATING THE CLINICAL UTILITY OF PATIENT ACCEPTABLE SYMPTOM STATE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., ÖZTÜRK M. A., et al.

EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

32. A case of pseudogout attack after zoledronic acid treatment in primary hyperparathyroidism

COŞKUN M., DEMİR E., TUFAN A., YALÇIN M. M., EROĞLU ALTINOVA A., AKTÜRK M. Y., et al.

Endobridge 2021, online, Turkey, 21 October 2021, (Full Text)

33. AAA hastalarında gastrointestinal sistem tutulumu

KIZMAZ E., YILDIRIM D., TUFAN A., ÖZTÜRK M. A., GÖKER B., KÜÇÜK H., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

34. Sistemik lupus eritematozus hastalarında akalküloz kolesistit: iki olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., Tahta E., GÖKER B., ÖZTÜRK M. A., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

35. Sistemik lupus eritematozusda prognostik nutrisyonel indeksin hastalık aktivitesi ile olan ilişkisinin araştırılması: Tek merkez deneyimi

Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., SATIŞ H., KÜÇÜK H., HAZNEDAROĞLU Ş., et al.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September 2021, (Full Text)

36. Akciğer skuamöz hücreli kanseri- granülomatoz polianjiitis birlikteliği: Olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text) Sustainable Development

37. Tedaviye dirençli Takayasu arteritinde tofasitinib kullanımı: iki olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

38. Antisentetaz sendromu- hemakromatozis birlikteliği: Nadir görülen bir olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.

Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September 2021, (Full Text)

39. Nadir görülen birliktelik: İmmünoglobulin G4 ilişkili hastalıkta anjiyomyomatoid fibröz histiyositom olgu sunumu

Baş D., Yıldırım D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

40. Nadir görülen bir olgu sunumu: VEXAS sendromu

YILDIRIM D., AKCAN E., PAMUK İ., Gökhan S., KÜÇÜK H., TUFAN A., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

41. Sistemik lupus eritematozus relapsing polikondrit birlikteliği: İki olgu Sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

42. Ailesel Akdeniz ateşi hastalarındakronik artrit: Klinik özellikler ve tedavi

AVANOĞLU GÜLER A., COŞKUN Ç., ÜNAL S., Tahta E., KARADENİZ H., Salman R. B., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

43. Yaşlı ankilozan spondilit hastalarında kırık riski ve ilişkili faktörler

ATAŞ N., CANDEMİR B., MURAT T., KARADENİZ H., Guler A. A., BABAOĞLU H., et al.

TRD 2020 ULUSAL ROMATOLOJİ BULUŞMASI, Turkey, 12 - 17 October 2020, (Summary Text)

44. Disease Characteristics of Psoriatic Arthritis Patients May Differ According to Age at Psoriasis Onset: Cross-sectional Analysis of Psoriatic Arthritis- International Database,

BİLGİN E., BAYINDIR Ö., KASAPOĞLU E., BAKIRCI S., SOLMAZ D., KİMYON G., et al.

Annual European Congress of Rheumatology,Frankfurt, Germany, 3 - 06 June 2020, (Summary Text)

45. Nedeni bilinmeyen sekonder intestinal lenfanjiektazili olgu, whipple hastalığı?

DEMİRBAŞ YÜCELDİ S., KARATAŞ A., aliyev e., KILIÇ G., ERGİN M., İBİŞ M., et al.

Gastroenteroloji Günleri, Turkey, 28 - 29 February 2020, (Summary Text)

46. Geç Başlangıçlı Ankilozan Spondilit Hastalarında Anti-TNF Alfa Tedavisinin Erken Yaşta Semptomları Başlayanlara Göre Etkinliği ve Güvenliği TÜRKBİO Veritabanı

USLU S., CAN G., ÇEFLE A., YILMAZ S., KOCAER S. B., YÜCE İNEL T., et al.

20. Ulusal Romatoloji Kongresi, Turkey, 16 - 20 October 2019

47. Komorbidite varlığı, aksiyal spondiloartritte ilk TNFitedavideki kalımı ve tedavinin etkinliğini azaltmaktadır:TÜRK-BİO verileri

EREZ Y., KARAKAS A., KOCAER S. B., YÜCE İNEL T., GÜLLE S., KÖKEN AVŞAR A., et al.

20. ULUSAL ROMATOLOJİ KONGRESİ, Turkey, 16 - 20 October 2019, vol.11

48. The Efficacy and Safety of Anti-TNF Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset The Data from TURKBIO Registry

USLU S., CAN G., CEFLE A., YILMAZ S., KOCAER S., İNEL T., et al.

ACR/ARHP Annual Meeting, Atlanta, USA, 17 - 20 October 2019, (Summary Text)

49. Familial Mediterranean Fever Related Damage Assessed By Auto-Inammatory Disease Damage Index (ADDI) and Associated Factors with Damage

TUFAN A., Armagan B., Bodakci E., Kasifoglu T., SATIŞ H., ATAŞ N., et al.

ACR/ARP Annual Meeting 2018, 19 October 2108 - 24 October 2018, (Summary Text)

50. Gelişmiş RA tedavisi almakta olup başka bir gelişmiş RA tedavisine geçen veya gelişmiş RA tedavisi-naif hastaların temel özellikleri ve tedavi yöntemi tercihlerinin ara analizi: Çok Merkezli, prospektif, gözlemsel çalışma

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

20. uLUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 16 - 20 October 2019, (Full Text)

51. Komorbidite varlığı, aksiyel spondiloartritte ilk TNFi tedavideki kalımı ve tedavinin etkinliğini azaltmaktadır: TÜRK-BİO verileri

EREZ Y., KARAKAŞ A., KOCAER S. B., YÜCE İNEL T., GÜLLE S., KÖKEN AVŞAR A., et al.

XX Ulusal Romatoloji Kongresi, Antalya, Turkey, 16 - 19 October 2019, vol.11, pp.1-252, (Summary Text)

52. PS-074 Behçet hastalığında anti TNF tedavisi ile ilişkili paradoksik palmoplantar psöriyaziste azatioprin etkinliği

KARADENİZ H., ATAŞ N., Guler A. A., BABAOĞLU H., SATIŞ H., Salman r. b., et al.

XX. Ulusal Romatoloji Kongresi, Turkey, 16 October 2019 - 20 October 2010, (Summary Text)

53. PS-073 Psikoz ile prezente olan nöro-Behçet vakasında 18F-FDG PET/MR ile tanı konulması

Guler A. A., ATAŞ N., KARADENİZ H., SATIŞ H., Salman r. b., BABAOĞLU H., et al.

XX. Ulusal Romatoloji Kongresi, Turkey, 16 - 20 October 2019, (Summary Text)

54. The effects of sacroiliac joint mobilization on pain, function, and mobility in patients with ankylosing spondylitis: report of two cases

BAĞLAN YENTÜR S., METE O., TUNA Z., TUFAN A., OSKAY D.

International Conference on Clinical Trials Pharmacoviligance, 23 - 24 September 2019, (Summary Text)

55. The Efficacy and Safety of Anti-TNF Alfa Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset The Data From TURKBIO Registry

USLU S., CAN G., CEFLE A., YILMAZ S., KOCAER S., INEL T., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 12 - 15 June 2019, (Summary Text)

56. The efficacy and safety of anti-tnf a treatment ın ankylosing spondylitis patients with late onset compared to those with adult onset the data from Türkbio registry

USLU S., CAN G., Cefle A., YILMAZ S., KOCAER S. B., YÜCE İNEL T., et al.

European congress of Rheumatology 2019, Madrid, Spain, 12 - 15 June 2019, vol.78, pp.896, (Full Text)

57. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

SATIŞ H., DEMİR B. N., BİLİCİ SALMAN R., TEMEL E., BABAOĞLU H., ATAŞ N., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY, Madrid, Spain, 12 - 15 June 2019, (Full Text)

58. DIAGNOSTIC UTILITY OF POSITRON EMISSION TOMOGRAPHY FOR THE EVALUATION OF PATIENTS WITH INFLAMMATION OF UNKNOWN ORIGIN

Salman R. B., Gulbahar S., SATIŞ H., Atas N., Babaoglu H., KARADENİZ H., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.1360-1361, (Summary Text)

59. THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY

Uslu S., CAN G., ÇEFLE A., YILMAZ S., Kocaer S. B., Inel T. Y., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.896, (Summary Text)

60. FREQUENCY, CHARACTERISTICS AND CLINICAL DETERMINANTS OF "PRODROME" IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

Babaoglu H., Atas N., Varan O., SATIŞ H., Salman R. B., AVANOĞLU GÜLER A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.585, (Summary Text)

61. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME

SATIŞ H., Demir B. N., Salman R. B., ÜLGEN TEMEL E., Babaoglu H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.1740, (Summary Text)

62. PREVALENCE, UNDERLYING FACTORS AND DAMAGE ASSOCIATED WITH CHRONIC PERSISTENT INFLAMMATION IN PATIENTS WITH FMF

Babaoglu H., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.571-572, (Summary Text)

63. APPLICATION OF AUTO-INFLAMMATORY DISEASE DAMAGE INDEX (ADDI) TO PATIENTS WITH FMF AND RELATED FACTORS WITH DAMAGE

Babaoglu H., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.1005, (Summary Text)

64. P2036 Familial Mediterranean fever related damage assessed by autoinflammatory disease damage index (ADDI) and associated factors with damage

BABAOĞLU H., Armagan B., Bodakci E., Kasifoglu T., SATIŞ H., ATAŞ N., et al.

The International Society of Systemic Auto-Inflammatory Diseases (ISSAID) 2019, 31 March - 03 April 2019, (Summary Text)

65. P2038 Work productivity and activity impairment in familial Mediterranean fever patients

erdem S., ATAŞ N., BABAOĞLU H., SATIŞ H., Salman r. b., VARAN Ö., et al.

The International Society of Systemic Auto-Inflammatory Diseases (ISSAID) 2019, 31 March - 03 April 2019, (Summary Text)

66. P1067 Familial Mediterranean fever associated infertility and underlying factord

ATAŞ N., Armagan B., Bodakci E., Kasifoglu T., SATIŞ H., Sari A., et al.

The International Society of Systemic Auto-Inflammatory Diseases (ISSAID) 2019, 31 March - 03 April 2019, (Summary Text)

67. Ailevi Akdeniz ateşine (FMF) bağlı kompozit hasar veilişkili faktörler

TUFAN A., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., ATAŞ N., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 October 2018, (Summary Text)

68. Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage

TUFAN A., ARMAĞAN B., BODAKÇİ E., KAŞİFOĞLU T., SATIŞ H., ATAŞ N., et al.

2019 ACR/ARP Annual Meeting, 19 - 24 October 2018, (Summary Text)

69. Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from the Turkbio Registry

BABAOĞLU H., GÖKER B., İNANÇ G. N., BİRLİK A. M., KOCA S. S., ÇEFLE A., et al.

American College of Rheumatology Congress’xx18, chicago, United States Of America, 19 - 24 October 2018, (Full Text) Sustainable Development

70. Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from Turkbio Registry

BABAOĞLU H., GÖKER B., İNANÇ G. N., BİRLİK A. M., KOCA S. S., CEFLE A., et al.

ACR/ARHP Annual Meeting, Chicago, USA, 2018., CHICAGO, United States Of America, 19 - 24 October 2018, (Summary Text) Sustainable Development

71. Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility

ATAŞ N., ARMAĞAN B., BODAKÇİ E., KAŞİFOĞLU T., SATIŞ H., SARI A., et al.

2018 ACR/ARHP Annual Meeting, CHICAGO, United States Of America, 19 - 24 October 2018, (Summary Text)

72. Romatoid Artritli Hastalarda Tofacitinib Klinik Deneyimi, TÜRKBİO Veritabanı Sonuçları

ÖNEN F., DALKILIÇ H. E., İNANÇ G. N., CAN G., PEHLİVAN Y., ERTÜRK Z., et al.

XVIII. Ulusal Romatoloji Kongresi, Antalya, Turkey, 18 - 22 October 2018

73. Interim Analysis of Baseline Characteristics and preferences of administration route of rheumatoid arthritis patients who are bio-naive or switched between advanced RA treatments A multicenter, prospective, observational study

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

2018 ACR/ARHP Annual Meeting, Şikago, United States Of America, 19 - 24 October 2018, vol.70, (Full Text)

74. Interim Analysis of Baseline Characteristics and Preferencesof Administration Route of Rheumatoid Arthritis PatientsWho Are Bio-Naïve or Switched between Advanced RATreatments A Multicenter, Prospective, ObservationalStudy

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

2018 ACR/ARHP Annual Meeting, CHICAGO, United States Of America, 19 - 24 October 2018, vol.70, (Full Text)

75. The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in psoriatic arthritis patients: Results from the TURKBIO registry.

YARKAN H., KENAR G., ÇAPAR S., CAN G., ZENGİN B., AKAR S., et al.

ACR/ARHP 2018, Şikago, United States Of America, 19 - 24 October 2018, vol.70, pp.1-3584, (Full Text)

76. Activity Tracker Bracelets Captures Familial Mediterranean Fever Attacks and Their Impact on Daily Physical Activities

BABAOĞLU H., VARAN Ö., ATAŞ N., SATIŞ H., ÖZTÜRK M. A., GÖKER B., et al.

2018 ACR/ARHP Annual Meeting, 19 - 24 October 2018, vol.70, (Full Text)

77. PS-015 Erişkin ailesel Akdeniz ateşi hastalarında kronik inflamasyon: Altta yatan nedenler ve amiloidozla ilişkisi

VARAN Ö., KÜÇÜK H., BABAOĞLU H., TECER D., ATAŞ N., Salman r. b., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

78. PS-240 Romatolojik hastalıklarda görülen interstisyel akciğer tutulumunun medikal yönetimi

SATIŞ H., Salman r. b., VARAN Ö., BABAOĞLU H., ATAŞ N., Türktaş H. Ş., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

79. Psoriyatik artritte mortalitede artışı saptanmamıştır.Ulusal psoriyatik artrit kohortu (PSART) verileri

ERDEN A., KILIÇ L., SOLMAZ D., BAKIRCI S., Kimyon G., Kasapoglu G. E., et al.

19. Ulusal Romatoloji Kongresi, BODRUM, Turkey, 26 - 30 September 2018, vol.10, (Summary Text)

80. Ankilozan spondilit hastalarında tümör nekroz faktör-alfa inhibitör tedavi yanıtına sigaranın etkisi TÜRK-BİO veritabanı sonuçları.

TUĞSAL H. Y., CAN G., ÇAPAR S., ZENGİN B., KENAR G., AKAR S., et al.

XIX. Ulusal Romatoloji Kongresi 2018, Muğla, Turkey, 26 - 30 September 2018, vol.10, pp.6-7, (Full Text)

81. Psoriyatik artritte mortalitede artış saptanmıştır:Ulusal psoriyatik artrit kohortu (PSART) verileri

ERDEN A., KILIÇ L., SOLMAZ D., ÜREYEN S. B., KİMYON G., GÜNAL E. K., et al.

19.Ulusal Romatoloji kongresi, BODRUM, Turkey, 26 - 30 September 2018, vol.10, pp.10-12, (Summary Text)

82. PS-020 Ailevi Akdeniz ateşi hastalarında infertilite sıklığı ve ilişkili faktörler

ATAŞ N., Armagan B., Bodakci E., Kasifoglu T., SATIŞ H., Sari A., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 September 2018, (Summary Text)

83. PS-068 Pulmoner semptomlarla romatoloji polikliniğine başvuran bağ doku hastalarındaki akciğer hastalıkları ve radyolojik paternleri

Salman r. b., SATIŞ H., ATAŞ N., BABAOĞLU H., VARAN Ö., Türktaş H. Ş., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

84. PS-007 Ailevi Akdeniz ateşi hastalarının atak öncesi prodrom sıklığı, özellikleri ve klinik faktörlerle olan ilişkisi

BABAOĞLU H., VARAN Ö., ATAŞ N., SATIŞ H., Salman r. b., HAZNEDAROĞLU Ş., et al.

XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

85. Behcet Disease and Periodontal condition

ORDUYILMAZ F., ÖZMERİÇ KURTULUŞ N., ELGÜN ÜLKAR S., GÜRBÜZ S., KÜÇÜK H., Bitik B., et al.

Europerio 9, 20 - 23 June 2018

86. The effect of family history on disease phenotypes in 1393 psoriatic arthritis patients

SOLMAZ D., ÜREYEN S., Kimyon G., Kasapoglu G. E., DOĞRU A., Bayindir O., et al.

EULAR 2018 Annual Europian Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.361, (Summary Text)

87. Geographical Differences in Psoriatic arthritis: A Transatlantic Comparison

ÜREYEN S., SOLMAZ D., Kimyon G., Kasapoglu G. E., DOĞRU A., Bayindir O., et al.

EULAR 2018 Annual Europian Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1042, (Summary Text)

88. ON DEMAND USE OF ANAKINRA FOR THE ATTACKS OF FAMILIAL MEDITERRANEAN FEVER (FMF)

Babaoglu H., Varan O., Kucuk H., Atas N., Satis H., Salman R. B., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.507-508, (Summary Text)

89. THE EFFECT OF SMOKING ON RESPONSE TO TUMOR NECROSIS FACTOR-ALPHA INHIBITOR TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS: RESULTS FROM THE TURKBIO REGISTRY

Tugsal H. Y., Can G., Capar S., Zengin B., Kenar G., Akar S., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.953, (Summary Text)

90. EFFECT OF INTERLEUKIN-1 ANTAGONISTS ON THE QUALITY OF LIFE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

Varan O., Kucuk H., Babaoglu H., Atas N., Satis H., Salman R. B., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.502, (Summary Text)

91. THE PREVALENCE OF SPONDYLOARTHROPATHY IN PATIENTS WITH TAKAYASU ARTERITIS

Guzel S., Armagan B., Varan O., Erden A., Kucuk H., Babaoglu H., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.429, (Summary Text)

92. IS THERE ANY DIFFERENCE IN RA PATIENTS FOR METHOTREXATE USE VS. LEFLUNOMIDE USE AS A CONCOMITANT TREATMENT WITH BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN TURKBIO REGISTRY?

Inanc N., Ozen G., Yalcinkaya Y., Dalkilic E., Koca S. S., Can G., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.611-612, (Summary Text)

93. SIMILAR EFFICACY OF TOFACITINIB ON DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT PREVIOUS BIOLOGICALS; RESULTS FROM THE TURKBIO REGISTRY

Zengin B., Inanc N., Akar S., Can G., Dalkilic E., TUFAN A., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1401-1402, (Summary Text)

94. Validity of the Patient-Rated Wrist Evaluation Questionnaire in Rheumatoid Hand

TUNA Z., METE O., TORE N. G., BAĞLAN YENTÜR S., OSKAY D., TUFAN A.

XXIIIrd Annual Congress of FESSH, Denmark, 13 - 16 June 2018, vol.43, pp.17-210, (Summary Text)

95. SLEEP QUALITY IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS SHOULD BE KEPT IN MIND

Deniz O., Satis H., Cavusoglu C., Salman R. B., Varan O., Atas N., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.305, (Summary Text)

96. USE OF BIOLOGICAL DMARDS IN PATIENTS WITH PRIMARY VASCULITIS; RESULTS FROM TURKBIO REGISTRY

YAZICI A., ÇEFLE A., Dalkilic E., Pehlivan Y., Can G., Goker B., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1470-1471, (Summary Text)

97. CANAKINUMAB USE IN ADULT FAMILIAL MEDITERRANEAN FEVER PATIENTS: A LARGE SINGLE CENTRE EXPERIENCE

Babaoglu H., Varan O., Kucuk H., Alas N., Satis H., Salman R. B., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1158, (Summary Text)

98. Romatoid artritli yaşlı hastalarda uyku kalitesi gözardı edilmemeli

DENİZ O., SATIŞ H., ÇAVUŞOĞLU Ç., BİLİCİ SALMAN R., VARAN Ö., ATAŞ N., et al.

11.Akademik Geriatri Kongresi, Turkey, 19 - 23 April 2018, (Full Text)

99. Genç Romatolojik Hastalarda Yorgunluğun Yaşam Kalitesine Etkisi

SARİ F., TORE N. G., OSKAY D., TUFAN A.

II. ULUSLARARASI GENÇLiK ARAŞTIRMALARI KONGRESİ, 25 - 29 October 2017, (Summary Text)

100. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry

İNANÇ G. N., ÖZEN G., YALÇINKAYAN Y., DALKILIÇ H. E., KOCA S. S., CAN G., et al.

ACR/ARHP 2017, San Diego, United States Of America, 3 - 08 November 2017, vol.69, pp.1-4481, (Full Text)

101. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmard in Turkbio Registry ?

İNANÇ G. N., ÖZEN G. E., yalçınkaya y., DALKILIÇ H. E., KOCA S. S., gerçek c., et al.

Arthritis Rheumatology, 3 - 08 November 2017, (Full Text)

102. Sistemik lupus eritematosus ve kad›n hastalar›n aileve sosyal yaflam›na etkileri

VARAN Ö., KÜÇÜK H., mercan r., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

17. Ulusal Romatoloji Kongresi, Turkey, 24 - 30 October 2017, (Summary Text)

103. Behçet tanılı hastada salmonella artriti görülmesi

ATAŞ N., BABAOĞLU H., VARAN Ö., GÜVEN S. C., TUFAN A., ÖZTÜRK M. A., et al.

18. Ulusal Romatoloji Kongresi, Turkey, 18 - 22 October 2017

104. Günlük romatoloji pratiğinde biyolojik tedavi alan hastaların değerlendirilmesi: TÜRK-BİO verileri.

ÖNEN F., CAN G., PEHLİVAN Y., DALKILIÇ H. E., ŞENEL S., KOCA S. S., et al.

XVIII ULUSAL ROMATOLOJİ KONGRESİ 2017, Antalya, Turkey, 18 - 22 October 2017, vol.9, pp.1-182, (Full Text)

105. Biyolojik ve hedefe yönelik sentetik ilaç tedavileri alan romatoid artritli hastalarda birlikte kullanılan metotreksat veya leflunomid tedavileri arasında fark var mı?

İNANÇ G. N., ÖZEN G., YALÇINKAYA Y., DALKILIÇ H. E., Koca S. S., CAN G., et al.

XVIII. Ulusal Romatoloji Kongresi, Turkey, 18 - 22 October 2017, (Summary Text)

106. Correlation between diseaseactivity, quality of life, level of disabilityand scapular dyskinesis in patient withrheumatoid arthritis

Delen M., OSKAY D., BAĞLAN YENTÜR S., TUNA Z., METE O., GÖKKURT A., et al.

XXII. FESSH Congress XII. EFSHT Congress, 21 - 24 June 2017, (Summary Text)

107. Serum Defensın Level In Systemıc Sclerosıs Patıents

emiroğlu t., KÜÇÜK H., GÖKER B., HAZNEDAROĞLU Ş., PAŞAOĞLU H., varan o., et al.

EULAR Annual European Congress of Rheumatology, 14 - 17 June 2017, (Summary Text)

108. Correlations between patient rated questionnaires and clinicans’ objectivemeasurements in rheumatoid hand:Preliminary results

METE O., TORE N. G., BAĞLAN YENTÜR S., SEVEN B., GÖKKURT A., TUNA Z., et al.

XXII. FESSH Congress XII. EFSHT Congress, 21 - 24 June 2017, (Summary Text)

109. Budd-Chiari Syndrome in Behçet’s Disease: A Retrospective Multicenter Study

AKYOL L., TOZ B., Bayindir O., ZENGİN O., CANSU Ü., YİĞİT M., et al.

EULAR 2017 Annual Europian Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.327-328, (Summary Text)

110. BUDD-CHIARI SYNDROME IN BEHCET'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D. U., Yigit M., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.327-328, (Summary Text)

111. PREDICTIVE VALUE OF PLATELET TO LYMPHOCYTE RATIO IN RENAL INVOLVEMENT IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS

Kucuk H., Tecer D., Varan O., Babaoglu H., Guven S. C., TUFAN A., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.608-609, (Summary Text)

112. SERUM DEFENSIN LEVEL IN SYSTEMIC SCLEROSIS PATIENTS

Emiroglu T., Kucuk H., Goker B., Haznedaroglu S., Pasaoglu H., Varan O., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1260-1261, (Summary Text)

113. IMPACT OF DISEASE ON FAMILY AND SOCIAL LIFE IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Babaoglu H., Varan O., Guven S. C., Tecer D., Kucuk H., TUFAN A., et al.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1216, (Summary Text)

114. THE RELATIONSHIPS BETWEEN THORACIC REGION INVOLVEMENT AND FUNCTIONS OF UPPER EXTREMITY, SCAPULAR KINEMATICS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: PILOT STUDY

Mete O., Oskay D., TUFAN A.

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1302, (Summary Text)

115. AMİLOİDOZ İLE KOMPLİKE AİLEVİ AKDENİZ ATEŞİ HASTALARINDA İNTERLÖKİN-1 İNHİBİTÖRLERİNİN ETKİNLİĞİ VE GÜVENLİĞİ

VARAN Ö., KÜÇÜK H., BABAOĞLU H., GÜVEN S. C., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

3. İlaç ve Tedavi Kongresi, Antalya, Turkey, 24 - 28 May 2017, (Summary Text)

116. Nailfold Capillaroscopy Findings in a Patient with Port - Wine Stain

GÜVEN S. C., KÜÇÜK H., TUFAN A.

MIRCIM 2017 TIHUD-TIP Joint Meeting, 11 - 14 May 2017, (Summary Text)

117. AN EASY METHOD FOR TRACKING ATTACK DATA OF AUTOINFLAMMATORY DISEASES: AUTOINFLAMMATORY DISEASE DIARY (AIDD) APPLICATION

TUFAN A., KÜÇÜK H., VARAN Ö., BABAOĞLU H.

9th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases., 4 - 07 May 2017, (Full Text)

118. Genetic Analysis of Inherited Autoinflammatory Disorders

TAHİR TURANLI E., Balamir A., KARACAN İ., Kireçtepe Aydın A., Sevinç N., Özkılınç M., et al.

9th International Congress of Familial Mediterranean Fever and Systemic Auto Inflammatory Disaeases, 4 - 07 May 2017, (Summary Text)

119. Observer Variability of Joint space with measurements is subject related in medial knee osteoarthritis

GÖKER B., HAZNEDAROĞLU Ş., TUFAN A., Block J.

ACR 2016 Annual Meeting, 11 - 16 November 2016, (Summary Text)

120. Romatoid Artrit Dirsek Tutulumu Azathioprın Tedavisi

KÜÇÜK H., VARAN Ö., TUFAN A., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., GÖKER B.

ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

121. Kronik Plevral Efüzyon Araştırılan FMF Hastasında Mezotelyoma Olgu Sunumu

KÜÇÜK H., VARAN Ö., TUFAN A., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., GÖKER B.

ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

122. SİSTEMİK SKLEROZLU HASTALARDA SERUM DEFENSİN DÜZEYLERİNİN BELİRLENMESİ

EMİROĞLU T., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.

ULUSAL ROMATOLOJİ, Turkey, 24 - 30 October 2016, (Full Text)

123. Kadın Hastalarda Sistemik Lupus Eritematosus un Aile ve Sosyal Yaşama Etkileri

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B.

ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

124. Sistemik Lupus Eritematosus ve Hiperimmünglobulin M Sendromu Nadir Görülen Bir Birliktelik

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B.

ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

125. WEGENER HASTALARINDA SERUM FERRİTİN DÜZEYİ İLE HASTALIK PROGRESYONU ARASINDAKİ İLİŞKİ

KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., BERİVAN B., GÖKER B., et al.

ULUSAL ROMATOLOJİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

126. otimmun iç kulak hastalığı olgu sunumu

GÜVEN S. C., KÜÇÜK H., TECER D., TUFAN A., VARAN Ö., GÖKER B.

ulusal romatoloji kongresi, Turkey, 24 - 30 October 2016, (Full Text)

127. Orbital inflamatuar lezyonların ayırıcı tanısında nadir bir klinik tablo Tolosa Hunt sendromu

GÜVEN S. C., KÜÇÜK H., VARAN Ö., TECER D., BABAOĞLU H., TUFAN A.

ULUSAL ROMATOLOJİ, Turkey, 24 - 30 October 2016, (Full Text)

128. Sistemik Lupus Eritematozus lu Hastalarin El Fonksiyonlarının İncelenmesi

BAĞLAN YENTÜR S., TUNA Z., METE O., GÖKKURT A., TORE N. G., SEVEN B., et al.

2. Ulusal Romatolojik Rehabilitasyon Kongresi, İstanbul, Turkey, 13 - 15 October 2016

129. Observer variability of joint space width measurements is subject related in medial knee osteoarthritis

GÖKER B., HAZNEDAROĞLU Ş., TUFAN A., BLOCK J.

Anerican College of Rheumatology Annual Meeting, 11 - 16 November 2016, (Summary Text)

130. Chorea Associated With Antiphospholipid Syndrome In Two Young Women With History of Pregnancy Losses

GÖKER B., KÜÇÜK H., FEYZA NUR K., VARAN Ö., TUFAN A., ÖZTÜRK M. A., et al.

15. Uluslararası Antifosfolipid Sendromu Kongresi, 21 - 24 September 2016, (Full Text) Sustainable Development

131. IgM nephropathy in a patient with antiphospholipid syndrome

KÜÇÜK H., KELEZ F. N., VARAN Ö., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

15TH INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID SYNDROME, 21 - 24 September 2016, (Summary Text)

132. Chorea associated with antiphoapholipid symdrome in 2 young women with pregnancy losses

GÖKER B., KELEZ F. N., KÜÇÜK H., VARAN Ö., TUFAN A., ÖZTÜRK M. A., et al.

15TH INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID SYNDROME, 21 - 24 September 2016, (Summary Text) Sustainable Development

133. Markers of inflammation in Behçet s syndrome

BİTİK B., KÜÇÜK H., VARAN Ö., YEŞİL N., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

17th International Conference on Behçet's Disease, 15 - 17 September 2016, (Summary Text)

134. ınterstisyel akciğer hastalıklarının ayırıcı tanısında nadir görülen bir durum sekestrasyon

merve ecem erdoğan y., KÜÇÜK H., VARAN Ö., TUFAN A., GÖKER B.

ulusal romatoloji kongresi, Turkey, 24 - 30 June 2016, (Full Text)

135. AB0526 Serum Ferritin as A Marker of Activity in Patients with Anca Associated Vasculitis

KÜÇÜK H., VARAN Ö., BERİVAN B., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş., et al.

eular KONGRE, 8 - 11 June 2016, (Full Text)

136. MARKERS OF SYSTEMIC INFLAMMATION IN BEHCET S SYNDROME

BERİVAN B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.

EULAR KONGRESİ, 8 - 11 June 2016, (Full Text)

137. AB0535 Assessment of Cardiovascular Risk in Patients with Granulomatosis with Poliangiitis Using The Score Risk Index

BERİVAN B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.

EULARr KONGRE, 8 - 11 June 2016, (Full Text)

138. ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH GRANULOMATOSIS WITH POLIANGIITIS USING THE SCORE RISK INDEX

Bitik B., Kucuk H., Varan O., Ozturk M. A., Haznedaroglu S., Goker B., et al.

Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.1088, (Summary Text)

139. SERUM FERRITIN AS A MARKER OF ACTIVITY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

Kucuk H., Varan O., Bitik B., Ozturk M. A., Goker B., Haznedaroglu S., et al.

Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.1084-1085, (Summary Text)

140. Romatoid Artritli Hastalarda Skapular Diskinezi İle Hastalık Aktivitesi Yaşam Kalitesi Ve Özür Seviyesi Arasındaki İlişkinin Araştırılması Pilot Çalışma

DELEN M., OSKAY D., BAĞLAN YENTÜR S., TUNA Z., METE O., GÖKKURT A., et al.

1. Ortopedik Rehabilitasyon Sempozyumu, İstanbul, Turkey, 14 - 15 May 2016, (Summary Text)

141. INVESTIGATION OF HAND FUNCTIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Yentur S. B., Tuna Z., Gokkurt A., Mete O., Tore G., TUFAN A., et al.

Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.1305-1306, (Summary Text)

142. Assessment of cardiovascular risk in patients with granulomatosis with polyangiitis using the score risk index

BİTİK B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.

EULAR 2016 European League Against Rheumatism, 8 - 11 June 2016, (Summary Text)

143. Serm ferritin asa marker of activity in patients with ANCA associated vasculitis

KÜÇÜK H., VARAN Ö., BİTİK B., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş., et al.

EULAR 2016 European League Against Rheumatism, 8 - 11 June 2016, (Summary Text)

144. Sistemik Lupus Eritematozus lu Hastaların El Fonksiyonlarının İncelenmesi

BAĞLAN YENTÜR S., TUNA Z., GÖKKURT A., METE O., TORE N. G., OSKAY D., et al.

15. ULUSAL EL VE ÜST EKSTREMİTE CERRAHİSİ KONGRESİ - 4. ULUSAL EL REHABİLİTASYONU KONGRESİ, Turkey, 11 - 15 May 2016

145. EFFECT OF PULSE CYCLOPHOSPHAMİDE ON PARENCHYMAL NEUROLOGIKAL INVOLVEMENT IN BEHCET SYNDROME

HAZNEDAROĞLU Ş., BİTİK B., RIDVAN M., KÜÇÜK H., TUFAN A., GÖKER B.

Australian Rheumatology Association in conjunction with Rheumatology Helt Professionals Association 57. Annual Scientific Meeting, 30 April - 04 May 2016, (Full Text)

146. Anakinra tedavisi sonrası klinik remisyon sağlananMilwaukee shoulder sendromu

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

147. GranÜlomatöz polianjitis hastasInda gastrointestinalsistem tutulumu: Olgu sunumu

KÜÇÜK H., VARAN Ö., TUFAN A., TECER D., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

148. Parenkimal nörolojik tutulumu olan behçet hastalarındaserum vitamin B12, homosistein ve metilmalonik asitdüzeylerinin sağlıklı kontroller ile karşlılaştırılması

BİTİK B., TUFAN A., MERCAN R., Elbeğ Ş., KÜÇÜK H., KÜÇÜKŞAHİN O., et al.

Ulusal Romatoloji Kongresi 2015, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

149. Anakinra tedavisi ile remisyona giren FMF ilişlkilispondilit

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

150. Sistemik lupus eritematozus göz tutulumu

KÜÇÜK H., VARAN Ö., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., HASANREİSOĞLU C. M., et al.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

151. ANCA iliflkili vaskülitlerde nötrofil-lenfosit oran›n›n yeri

KÜÇÜK H., GÖKER B., DUMLUDAĞ B., ERTEN Y., BİTİK B., MERCAN R., et al.

2015 ULUSAL ROMATOLOJİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

152. Granülomatöz polianjitis hastasında mukoza vecilt tutulumu olgu sunumu

KÜÇÜK H., VARAN Ö., TECER D., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

2015 Ulusal Romatoloji Kongresi, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

153. Melkersson-Rosenthal sendromu ve oligoartritliolgu sunumu

KÜÇÜK H., VARAN Ö., BİTİK B., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

154. Hidroksiklorokin kullanımına bağlı gelişenmyastenia gravis

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

155. Hareket kısıtlılığına neden olan yaygın kalsinozis cutis

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.

2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

156. Ailevi Akdeniz ateşi hastalarında süreğen akut faz yüksekliği gerçekte inflamasyon subklinik mi

ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., TUFAN A.

16. Ulusal Romatoloji Kongresi, Turkey, 28 October - 01 November 2015

157. underlying causes of persistantly elevated acute phase reactants in patients with familial mediterranean fever

mercan r., bitik b., eren r., DUMLUDAĞ B., turan a., KÜÇÜK H., et al.

8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, (Summary Text)

158. magnetic resonance imaging features of familial mediterranean fever associated spondyloarthropathies

turan a., mercan r., berivan b., KÜÇÜK H., ÖZTÜRK M. A., TUFAN A.

8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, (Summary Text)

159. Serum uric acid levels in patients with Familial Mediterranean Fever and healthy controls

bitik b., ünverdi s., TUFAN A., yeşil n., ÖZTÜRK M. A., duranay m.

8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, vol.13, pp.83, (Summary Text)

160. Underlying causes of persistently elevated acute phase reactants in patiens with Familial Mediterranean Fever

RIDVAN M., BERİVAN B., EREN SADİOĞLU R., DUMLUDAĞ B., TURAN A., KÜÇÜK H., et al.

8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, vol.13, pp.139

161. Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis

TURAN A., RIDVAN M., BERİVAN B., KÜÇÜK H., ÖZTÜRK M. A., TUFAN A.

10.1186/1546-0096-13-S1-P114, 30 September - 03 October 2015, vol.13, pp.114

162. Ankılozan spondılıtlı hastalarda kınezyofobının yaşam kalıtesı fonksıyonel durum hastalık aktıvıtesi ve depresyon üzerıne etkısı

OSKAY D., TUNA Z., DÜZGÜN İ., BAĞLAN YENTÜR S., ELBASAN B., YAKUT Y., et al.

5. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Turkey, 21 - 24 May 2015, (Summary Text)

163. The impact of kinesiophobia on quality of life functional status disease activity and depression in patients with ankylosingspondylitis

OSKAY D., TUNA Z., DÜZGÜN İ., YAKUT Y., ELBASAN B., BAĞLAN YENTÜR S., et al.

5. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Turkey, 20 - 24 May 2015, vol.26, (Summary Text)

164. Ankilozan spondilit hastalarının hastalık bilgi düzeylerinin belirlenmesi

GÖKKURT A., BAĞLAN YENTÜR S., TUNA Z., OSKAY D., TUFAN A.

5. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Turkey, 20 - 24 May 2015, (Summary Text)

165. Sistemik lupus eritematozuslu hastalarda kinezyofobi ile ağrı, fiziksel aktivite, depresyon, yorgunluk, yaşam kalitesi ve hastalık aktivitesi arasındaki ilişki

Bağlan Yentür S., Karatay S., Tufan A., Oskay D., Tuna Z.

5. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Bolu, Turkey, 20 May 2015, (Summary Text)

166. Determining disease knowledge level in patients with ankylosingspondylitis

GÖKKURT A., BAĞLAN YENTÜR S., TUNA Z., OSKAY D., TUFAN A.

5. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Turkey, 20 - 24 May 2015, vol.26, (Summary Text)

167. vitaminB12 homocystein and methylmalonic acid levels in patients with neuro behcet s syndrome

bitik b., TUFAN A., mercan r., KÜÇÜK H., KÜÇÜKŞAHİN O., ÖZTÜRK M. A., et al.

EULAR european league againts rheumatism annual meeting, 10 - 13 June 2015, (Summary Text)

168. MANAGEMENT OF GOUT IN DIFFERENT CLINICAL SPECIALTIES IN TURKEY

ÖZTÜRK M. A., ONAT A. M., KISACIK B., KAYA A., ÇOBANKARA V., PAMUK Ö. N., et al.

16th Annual European Congress of Rheumatology - European League Against Rheumatism, 10 - 13 June 2015, vol.74, pp.12061-1206

169. Neutrophil Lymphocyte Ratio Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis

GÖKER B., HAZNEDAROĞLU Ş., KÜÇÜK H., VARAN Ö., BERİVAN B., TUFAN A., et al.

Neutrophil/Lymphocyte Ratio: Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis?, 6 - 11 November 2015, vol.67